Skip to main content
Psoriatic Arthritis ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
Crosswords
PsA Guidelines
Publish date:
October 13, 2022
Recommended Reading
PsA: Sustained improvement in dactylitis with tofacitinib
Psoriatic Arthritis ICYMI
Elbow tenderness and swollen joints
Psoriatic Arthritis ICYMI
Brodalumab suicide risk similar to other biologics, postmarket study finds
Psoriatic Arthritis ICYMI
Apremilast alleviates severe psoriasis in some children, data show
Psoriatic Arthritis ICYMI
Psoriasis, psoriatic arthritis insurance coverage remains restrictive
Psoriatic Arthritis ICYMI
Apremilast may have some cardiometabolic benefits in patients with psoriasis
Psoriatic Arthritis ICYMI
Commentary: Disease Activity, Progression to Psoriasis, and More in PsA, October 2022
Psoriatic Arthritis ICYMI
Sex differences seen in inflammatory arthritis health care use
Psoriatic Arthritis ICYMI
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Psoriatic Arthritis ICYMI
Previous endemic coronavirus encounters linked with long COVID
Psoriatic Arthritis ICYMI
Psoriatic Arthritis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge